StockData

Onconetix vs Quantum Cyber

ONCO and QUCY side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How ONCO and QUCY compare

Quantum Cyber grew revenue faster over the last twelve months (−39.9% versus −51.3% for Onconetix).

Onconetix keeps more of each dollar of sales as profit, with a net margin of −1579% compared with −3018% at Quantum Cyber.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricONCOQUCY
Size and price
Market cap$11.8M–
Share price$3.00$0.580
Change, 1 year−99.7%−60.3%
Change, 5 years−100.0%−94.1%
Beta (5Y)–2.15
Employees123
StockData Score
Total score33
Valuation score1 (better)0
Growth score11
Performance score01 (better)
Health score11
Dividend score00
Valuation
P/S18.3×–
P/B0.9×–
Growth
Revenue growth (TTM)−51.3%−39.9% (better)
Revenue growth, 5Y average–1.7%
Profitability
Gross margin80.4% (better)72.6%
Operating margin−2525% (better)−3005%
Net margin−1579% (better)−3018%
FCF margin–−2045%
Return on equity−105% (better)−141%
Return on invested capital−196% (better)−324%
Financial health
Interest coverage−52.4×−43.2× (better)
Current ratio2.215.56 (better)
Altman Z-score−12.36–
Piotroski F-score6 (better)2
Dividends and buybacks
Shareholder yield0.00%–
Ownership
Held by institutions1.7%2.4%
Held by insiders40.3%–
Insider net buying, 12 months$8.4K (better)$0
Short interest, % of float40.6%–

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.